NYTOL

This brand name is authorized in Canada, Ecuador, Ireland, Malta, Mexico, United Kingdom

Active ingredients

The drug NYTOL contains one active pharmaceutical ingredient (API):

1 Diphenhydramine UNII TC2D6JAD40 - DIPHENHYDRAMINE HYDROCHLORIDE

Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H1-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep. Read about Diphenhydramine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NYTOL ONE-A-NIGHT Tablet Diphenhydramine	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AA02	Diphenhydramine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AA Aminoalkyl ethers
Discover more medicines within R06AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01934414
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4958-MEE-0220
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 237152, 237153
Country: MT	Medicines Authority	Identifier(s): AA274/01101
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 567M94